10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

002800 (Sinsin) Stock Analysis
Buy, Hold or Sell?

Let's analyze Sinsin together

I guess you are interested in Sinsin Pharmaceutical Co. Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Sinsin’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Sinsin’s Price Targets

I'm going to help you getting a better view of Sinsin Pharmaceutical Co. Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Sinsin Pharmaceutical Co. Ltd

I send you an email if I find something interesting about Sinsin Pharmaceutical Co. Ltd.

1. Quick Overview

1.1. Quick analysis of Sinsin (30 sec.)










1.2. What can you expect buying and holding a share of Sinsin? (30 sec.)

How much money do you get?

How much money do you get?
β‚©0.00
When do you have the money?
1 year
How often do you get paid?
42.3%

What is your share worth?

Current worth
β‚©4,369.08
Expected worth in 1 year
β‚©4,683.51
How sure are you?
69.2%

+ What do you gain per year?

Total Gains per Share
β‚©314.43
Return On Investment
5.3%

For what price can you sell your share?

Current Price per Share
β‚©5,900.00
Expected price per share
β‚©5,500 - β‚©6,320
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Sinsin (5 min.)




Live pricePrice per Share (EOD)
β‚©5,900.00
β‚©4,369.08

2.2. Growth of Sinsin (5 min.)




Is Sinsin growing?

Current yearPrevious yearGrowGrow %
How rich?$46.3m$43.7m$1.9m4.3%

How much money is Sinsin making?

Current yearPrevious yearGrowGrow %
Making money$966.6k$754.9k$211.6k21.9%
Net Profit Margin5.0%3.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Sinsin (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Sinsin?

Welcome investor! Sinsin's management wants to use your money to grow the business. In return you get a share of Sinsin.

First you should know what it really means to hold a share of Sinsin. And how you can make/lose money.

Speculation

The Price per Share of Sinsin is β‚©5,900. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sinsin.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sinsin, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is β‚©4,369.08. Based on the TTM, the Book Value Change Per Share is β‚©78.61 per quarter. Based on the YOY, the Book Value Change Per Share is β‚©30.23 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is β‚©0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sinsin.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 β‚©% of Price per Shareβ‚©% of Price per Shareβ‚©% of Price per Shareβ‚©% of Price per Shareβ‚©% of Price per Shareβ‚©% of Price per Share
Usd Eps0.050.0%0.060.0%0.050.0%0.060.0%0.030.0%0.030.0%
Usd Book Value Change Per Share0.030.0%0.060.0%0.020.0%0.040.0%0.020.0%0.120.0%
Usd Dividend Per Share0.000.0%0.000.0%0.020.0%0.010.0%0.010.0%0.010.0%
Usd Total Gains Per Share0.030.0%0.060.0%0.040.0%0.050.0%0.030.0%0.130.0%
Usd Price Per Share3.53-3.90-4.14-3.85-4.47-4.61-
Price to Earnings Ratio19.02-19.57--6.61-95.32-34.64-28.12-
Price-to-Total Gains Ratio107.32-115.84--38.36--264.28--159.57--96.76-
Price to Book Ratio1.15-1.29-1.43-1.34-1.65-1.72-
Price-to-Total Gains Ratio107.32-115.84--38.36--264.28--159.57--96.76-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.13
Number of shares242
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share0.060.02
Usd Total Gains Per Share0.060.03
Gains per Quarter (242 shares)13.326.89
Gains per Year (242 shares)53.2627.55
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10534362118
2010796124346
30160149196474
402132022585102
5026625531107130
6032030837128158
7037336144149186
8042641450171214
9047946756192242
10053352062213270

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.01.00.091.7%13.07.00.065.0%18.08.00.069.2%18.08.00.069.2%
Book Value Change Per Share4.00.00.0100.0%9.03.00.075.0%12.08.00.060.0%18.08.00.069.2%18.08.00.069.2%
Dividend per Share0.00.04.00.0%2.00.010.016.7%5.00.015.025.0%11.00.015.042.3%11.00.015.042.3%
Total Gains per Share4.00.00.0100.0%9.03.00.075.0%12.08.00.060.0%18.08.00.069.2%18.08.00.069.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Sinsin Pharmaceutical Co. Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--46.96278.607-40%30.228+55%59.819-21%31.459+49%168.042-72%
Book Value Per Share--4369.0834304.559+1%4121.294+6%4107.832+6%3932.211+11%3873.549+13%
Current Ratio--0.8720.901-3%0.966-10%0.977-11%1.031-15%1.131-23%
Debt To Asset Ratio--0.4980.497+0%0.504-1%0.506-2%0.519-4%0.526-5%
Debt To Equity Ratio--0.9860.983+0%1.013-3%1.024-4%1.082-9%1.114-12%
Dividend Per Share----0%25.000-100%8.333-100%9.200-100%14.500-100%
Enterprise Value--10809004000.00020007175797.500-46%26710124687.500-60%20331729942.500-47%33724112102.000-68%35649622518.846-70%
Eps--66.24491.028-27%71.096-7%79.766-17%43.111+54%41.994+58%
Ev To Sales Ratio--0.1070.187-43%0.262-59%0.200-47%0.419-75%0.475-78%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Market Cap89505950000.000+15%76459320000.00084461758750.000-9%89619728750.000-15%83399823750.000-8%96939495000.000-21%99827724807.692-23%
Net Profit Margin--0.0400.050-21%0.039+1%0.045-13%0.023+75%0.026+55%
Operating Margin----0%-0%0.016-100%-0.0070%0.000-100%
Operating Ratio--1.2991.510-14%1.557-17%1.411-8%1.132+15%1.170+11%
Pb Ratio1.350+15%1.1541.294-11%1.434-20%1.338-14%1.645-30%1.718-33%
Pe Ratio22.266+15%19.02119.566-3%-6.607+135%95.321-80%34.636-45%28.120-32%
Price Per Share5900.000+15%5040.0005567.500-9%5907.500-15%5497.500-8%6390.000-21%6580.385-23%
Price To Free Cash Flow Ratio----1.4700%-8.2270%-125.9860%-85.0540%-67.0410%
Price To Total Gains Ratio125.634+15%107.321115.843-7%-38.365+136%-264.280+346%-159.570+249%-96.763+190%
Quick Ratio---0.409-100%0.575-100%0.559-100%0.626-100%0.695-100%
Return On Assets--0.0080.011-29%0.009-11%0.010-20%0.005+47%0.005+50%
Return On Equity--0.0150.021-29%0.017-12%0.019-22%0.010+47%0.010+46%
Total Gains Per Share--46.96278.607-40%55.228-15%68.153-31%40.659+16%182.542-74%
Usd Book Value--46396823.20045711617.000+1%43765462.036+6%43622504.568+6%41757521.209+11%41134577.772+13%
Usd Book Value Change Per Share--0.0330.055-40%0.021+55%0.042-21%0.022+49%0.118-72%
Usd Book Value Per Share--3.0583.013+1%2.885+6%2.875+6%2.753+11%2.711+13%
Usd Dividend Per Share----0%0.018-100%0.006-100%0.006-100%0.010-100%
Usd Enterprise Value--7566302.80014005023.058-46%18697087.281-60%14232210.960-47%23606878.471-68%24954735.763-70%
Usd Eps--0.0460.064-27%0.050-7%0.056-17%0.030+54%0.029+58%
Usd Free Cash Flow---740185.710-100%-154802.7370%465126.923-100%-747346.8150%-2460038.0860%
Usd Market Cap62654165.000+15%53521524.00059123231.125-9%62733810.125-15%58379876.625-8%67857646.500-21%69879407.365-23%
Usd Price Per Share4.130+15%3.5283.897-9%4.135-15%3.848-8%4.473-21%4.606-23%
Usd Profit--703468.500966661.166-27%754991.220-7%847062.523-17%457808.311+54%445950.865+58%
Usd Revenue--17716950.30018722899.043-5%18169629.853-2%17912642.791-1%15823006.488+12%14811158.198+20%
Usd Total Gains Per Share--0.0330.055-40%0.039-15%0.048-31%0.028+16%0.128-74%
 EOD+4 -3MRQTTM+7 -23YOY+12 -193Y+10 -235Y+20 -1110Y+16 -16

3.3 Fundamental Score

Let's check the fundamental score of Sinsin Pharmaceutical Co. Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1522.266
Price to Book Ratio (EOD)Between0-11.350
Net Profit Margin (MRQ)Greater than00.040
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.872
Debt to Asset Ratio (MRQ)Less than10.498
Debt to Equity Ratio (MRQ)Less than10.986
Return on Equity (MRQ)Greater than0.150.015
Return on Assets (MRQ)Greater than0.050.008
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Sinsin Pharmaceutical Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.481
Ma 20Greater thanMa 505,874.000
Ma 50Greater thanMa 1006,051.600
Ma 100Greater thanMa 2005,785.900
OpenGreater thanClose5,840.000
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Sinsin Pharmaceutical Co. Ltd

Sinsin Pharmaceutical Co., Ltd manufactures and sells pharmaceutical products in South Korea. It offers various medicinal products, such as plaster, aerosol, topical liquid, emollient, hygiene, and ointment products, as well as adhesive bandages, mosquito repellents, anti-perspirants, cooling sheets, bruise treatment creams, and other products. The company also develops transdermal drug delivery system, and bag on valve inhaler and aerosol solubilzation system. In addition, it exports its products to approximately 30 countries worldwide. The company was founded in 1959 and is headquartered in Sejong, South Korea.

Fundamental data was last updated by Penke on 2025-06-22 15:29:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Sinsin earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compareΒ Sinsin to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 4.0%Β means thatΒ ₩0.04 for each ₩1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sinsin Pharmaceutical Co. Ltd:

  • The MRQ is 4.0%. The company is making a profit. +1
  • The TTM is 5.0%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ4.0%TTM5.0%-1.0%
TTM5.0%YOY3.9%+1.1%
TTM5.0%5Y2.3%+2.7%
5Y2.3%10Y2.6%-0.3%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Sinsin is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Sinsin to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • 0.8% Return on Assets means thatΒ Sinsin generatedΒ ₩0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sinsin Pharmaceutical Co. Ltd:

  • The MRQ is 0.8%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 1.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.8%TTM1.1%-0.3%
TTM1.1%YOY0.9%+0.2%
TTM1.1%5Y0.5%+0.6%
5Y0.5%10Y0.5%+0.0%
4.3.1.3. Return on Equity

Shows how efficient Sinsin is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Sinsin to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • 1.5% Return on Equity means Sinsin generated ₩0.02Β for eachΒ ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sinsin Pharmaceutical Co. Ltd:

  • The MRQ is 1.5%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.1%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.5%TTM2.1%-0.6%
TTM2.1%YOY1.7%+0.4%
TTM2.1%5Y1.0%+1.1%
5Y1.0%10Y1.0%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Sinsin Pharmaceutical Co. Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Sinsin is operatingΒ .

  • Measures how much profit Sinsin makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Sinsin to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0%Β means the company generated ₩0.00 Β for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sinsin Pharmaceutical Co. Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.7%+0.7%
5Y-0.7%10Y0.0%-0.8%
4.3.2.2. Operating Ratio

Measures how efficient Sinsin is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.30 means that the operating costs are ₩1.30 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Sinsin Pharmaceutical Co. Ltd:

  • The MRQ is 1.299. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.510. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.299TTM1.510-0.211
TTM1.510YOY1.557-0.047
TTM1.5105Y1.132+0.378
5Y1.13210Y1.170-0.038
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Sinsin Pharmaceutical Co. Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Sinsin is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.87Β means the company has ₩0.87 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Sinsin Pharmaceutical Co. Ltd:

  • The MRQ is 0.872. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.901. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.872TTM0.901-0.029
TTM0.901YOY0.966-0.064
TTM0.9015Y1.031-0.130
5Y1.03110Y1.131-0.100
4.4.3.2. Quick Ratio

Measures if Sinsin is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Sinsin to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.00Β means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sinsin Pharmaceutical Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.409-0.409
TTM0.409YOY0.575-0.167
TTM0.4095Y0.626-0.217
5Y0.62610Y0.695-0.069
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Sinsin Pharmaceutical Co. Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of SinsinΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Sinsin to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.50Β means that Sinsin assets areΒ financed with 49.8% credit (debt) and the remaining percentage (100% - 49.8%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Sinsin Pharmaceutical Co. Ltd:

  • The MRQ is 0.498. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.497. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.498TTM0.497+0.001
TTM0.497YOY0.504-0.007
TTM0.4975Y0.519-0.022
5Y0.51910Y0.526-0.007
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Sinsin is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Sinsin to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 98.6% means that company has ₩0.99 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sinsin Pharmaceutical Co. Ltd:

  • The MRQ is 0.986. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.983. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.986TTM0.983+0.003
TTM0.983YOY1.013-0.030
TTM0.9835Y1.082-0.099
5Y1.08210Y1.114-0.033
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every ₩1 in earnings Sinsin generates.

  • Above 15 is considered overpriced butΒ always compareΒ Sinsin to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 19.02 means the investor is paying ₩19.02Β for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sinsin Pharmaceutical Co. Ltd:

  • The EOD is 22.266. Based on the earnings, the company is fair priced.
  • The MRQ is 19.021. Based on the earnings, the company is fair priced.
  • The TTM is 19.566. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD22.266MRQ19.021+3.246
MRQ19.021TTM19.566-0.545
TTM19.566YOY-6.607+26.173
TTM19.5665Y34.636-15.070
5Y34.63610Y28.120+6.516
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sinsin Pharmaceutical Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-1.470+1.470
TTM-1.470YOY-8.227+6.757
TTM-1.4705Y-85.054+83.584
5Y-85.05410Y-67.041-18.013
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Sinsin is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 1.15 means the investor is paying ₩1.15Β for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Sinsin Pharmaceutical Co. Ltd:

  • The EOD is 1.350. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.154. Based on the equity, the company is underpriced. +1
  • The TTM is 1.294. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.350MRQ1.154+0.197
MRQ1.154TTM1.294-0.140
TTM1.294YOY1.434-0.140
TTM1.2945Y1.645-0.351
5Y1.64510Y1.718-0.073
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Tax Provision  4,629192,014196,644-127,18069,463-11,05558,409-123,986-65,577



6.2. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in KRW. All numbers in thousands.

Summary
Total Assets131,931,492
Total Liabilities65,650,316
Total Stockholder Equity66,596,005
 As reported
Total Liabilities 65,650,316
Total Stockholder Equity+ 66,596,005
Total Assets = 131,931,492

Assets

Total Assets131,931,492
Total Current Assets54,364,637
Long-term Assets77,566,855
Total Current Assets
Total Current Assets  (as reported)54,364,637
Total Current Assets  (calculated)0
+/- 54,364,637
Long-term Assets
Long-term Assets  (as reported)77,566,855
Long-term Assets  (calculated)0
+/- 77,566,855

Liabilities & Shareholders' Equity

Total Current Liabilities62,344,979
Long-term Liabilities3,305,337
Total Stockholder Equity66,596,005
Total Current Liabilities
Total Current Liabilities  (as reported)62,344,979
Total Current Liabilities  (calculated)0
+/- 62,344,979
Long-term Liabilities
Long-term Liabilities  (as reported)3,305,337
Long-term Liabilities  (calculated)0
+/- 3,305,337
Total Stockholder Equity
Total Stockholder Equity (as reported)66,596,005
Total Stockholder Equity (calculated)0
+/- 66,596,005
Other
Net Invested Capital 66,596,005
Net Working Capital -7,980,342



6.3. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
> Total Assets 
107,919,651
118,031,599
126,189,238
129,555,899
129,237,818
133,629,441
136,898,021
121,667,139
118,134,054
119,871,743
119,646,692
117,441,418
114,307,218
117,517,990
124,135,408
123,933,185
121,213,081
121,532,255
125,825,704
126,797,648
124,409,302
126,775,080
128,382,645
129,229,349
129,484,086
131,931,492
131,931,492129,484,086129,229,349128,382,645126,775,080124,409,302126,797,648125,825,704121,532,255121,213,081123,933,185124,135,408117,517,990114,307,218117,441,418119,646,692119,871,743118,134,054121,667,139136,898,021133,629,441129,237,818129,555,899126,189,238118,031,599107,919,651
   > Total Current Assets 
44,805,689
45,860,546
48,700,069
47,803,673
44,589,124
43,783,067
48,165,175
42,231,595
39,679,508
41,340,419
41,653,909
39,565,251
36,467,370
40,290,000
47,507,842
47,840,175
45,047,532
46,323,590
49,434,211
51,135,488
47,107,680
50,292,467
52,330,630
54,068,804
51,492,327
54,364,637
54,364,63751,492,32754,068,80452,330,63050,292,46747,107,68051,135,48849,434,21146,323,59045,047,53247,840,17547,507,84240,290,00036,467,37039,565,25141,653,90941,340,41939,679,50842,231,59548,165,17543,783,06744,589,12447,803,67348,700,06945,860,54644,805,689
       Cash And Cash Equivalents 
1,893,820
1,124,549
879,387
559,944
1,129,922
1,052,068
850,787
2,515,791
2,504,097
1,225,513
776,677
895,841
799,332
0
0
0
2,240,063
1,850,000
1,262,165
818,799
346,456
607,253
790,229
3,071,386
539,853
0
0539,8533,071,386790,229607,253346,456818,7991,262,1651,850,0002,240,063000799,332895,841776,6771,225,5132,504,0972,515,791850,7871,052,0681,129,922559,944879,3871,124,5491,893,820
       Short-term Investments 
280,000
280,000
280,000
280,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000280,000280,000280,000280,000
       Net Receivables 
28,787,263
29,356,429
30,763,692
27,272,983
25,807,100
25,378,522
28,261,277
27,229,744
24,004,807
24,859,136
25,201,714
25,310,528
23,236,980
23,435,142
30,683,240
30,597,479
27,723,908
25,712,696
28,277,709
30,963,924
27,975,096
28,393,057
32,222,704
31,563,260
30,604,731
0
030,604,73131,563,26032,222,70428,393,05727,975,09630,963,92428,277,70925,712,69627,723,90830,597,47930,683,24023,435,14223,236,98025,310,52825,201,71424,859,13624,004,80727,229,74428,261,27725,378,52225,807,10027,272,98330,763,69229,356,42928,787,263
       Inventory 
9,497,620
10,700,446
12,321,936
13,243,894
12,965,631
10,818,445
12,227,292
11,821,778
12,370,512
14,546,125
12,594,969
10,289,158
10,369,769
13,372,149
14,808,390
14,978,585
14,389,575
14,963,522
15,385,467
14,313,874
15,732,501
18,018,344
15,595,917
15,341,159
16,642,693
0
016,642,69315,341,15915,595,91718,018,34415,732,50114,313,87415,385,46714,963,52214,389,57514,978,58514,808,39013,372,14910,369,76910,289,15812,594,96914,546,12512,370,51211,821,77812,227,29210,818,44512,965,63113,243,89412,321,93610,700,4469,497,620
       Other Current Assets 
4,267,673
4,231,777
4,278,952
4,038,750
4,375,744
4,354,991
4,560,160
550,775
729,202
611,905
93,984
138,728
145,054
164,698
616,624
665,835
659,076
379,081
472,499
488,682
195,069
216,246
228,274
245,045
272,003
0
0272,003245,045228,274216,246195,069488,682472,499379,081659,076665,835616,624164,698145,054138,72893,984611,905729,202550,7754,560,1604,354,9914,375,7444,038,7504,278,9524,231,7774,267,673
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
76,165,549
75,208,665
76,391,493
75,662,160
77,301,622
76,482,613
76,052,015
75,160,545
77,991,759
77,566,855
77,566,85577,991,75975,160,54576,052,01576,482,61377,301,62275,662,16076,391,49375,208,66576,165,5490000000000000000
       Property Plant Equipment 
58,260,957
67,340,037
72,699,074
76,989,732
80,219,176
85,495,101
70,188,405
71,080,413
70,033,985
70,062,209
69,492,587
69,370,420
69,345,396
68,667,349
68,063,038
67,467,648
66,824,773
66,056,927
67,213,674
66,637,651
68,263,614
67,646,048
66,823,224
66,103,426
65,717,653
0
065,717,65366,103,42666,823,22467,646,04868,263,61466,637,65167,213,67466,056,92766,824,77367,467,64868,063,03868,667,34969,345,39669,370,42069,492,58770,062,20970,033,98571,080,41370,188,40585,495,10180,219,17676,989,73272,699,07467,340,03758,260,957
       Goodwill 
297,099
297,099
297,099
297,099
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000297,099297,099297,099297,099
       Long Term Investments 
106,353
107,277
108,161
108,954
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000108,954108,161107,277106,353
       Intangible Assets 
603,231
597,474
592,351
588,494
585,555
513,483
512,951
499,420
499,065
499,065
499,065
499,065
499,065
544,938
555,389
587,406
592,290
588,908
585,525
586,506
586,318
582,530
580,708
576,820
580,532
0
0580,532576,820580,708582,530586,318586,506585,525588,908592,290587,406555,389544,938499,065499,065499,065499,065499,065499,420512,951513,483585,555588,494592,351597,474603,231
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000
> Total Liabilities 
53,265,008
63,064,228
70,483,932
73,198,794
72,874,756
76,893,217
81,238,305
63,861,685
61,938,907
64,487,614
64,589,398
62,603,439
59,380,567
62,126,690
66,322,343
64,604,356
61,515,083
61,855,378
63,154,496
62,982,090
62,318,878
65,263,916
64,239,914
64,012,756
63,915,345
65,650,316
65,650,31663,915,34564,012,75664,239,91465,263,91662,318,87862,982,09063,154,49661,855,37861,515,08364,604,35666,322,34362,126,69059,380,56762,603,43964,589,39864,487,61461,938,90763,861,68581,238,30576,893,21772,874,75673,198,79470,483,93263,064,22853,265,008
   > Total Current Liabilities 
30,722,985
25,294,811
30,996,830
31,187,729
34,782,037
38,721,557
42,497,495
32,163,643
34,382,056
37,976,284
39,492,286
38,643,948
33,919,034
37,844,042
43,749,075
43,533,045
42,327,458
46,231,116
48,934,679
48,920,932
51,719,960
56,094,386
56,474,329
57,823,628
59,100,525
62,344,979
62,344,97959,100,52557,823,62856,474,32956,094,38651,719,96048,920,93248,934,67946,231,11642,327,45843,533,04543,749,07537,844,04233,919,03438,643,94839,492,28637,976,28434,382,05632,163,64342,497,49538,721,55734,782,03731,187,72930,996,83025,294,81130,722,985
       Short-term Debt 
1,137,480
937,480
1,137,480
15,600,330
14,749,667
15,960,633
17,737,443
7,058,269
9,915,987
15,612,320
17,039,473
15,055,545
12,719,612
13,265,182
15,095,726
14,091,789
11,793,844
13,613,288
14,314,810
13,473,309
0
0
0
0
0
0
00000013,473,30914,314,81013,613,28811,793,84414,091,78915,095,72613,265,18212,719,61215,055,54517,039,47315,612,3209,915,9877,058,26917,737,44315,960,63314,749,66715,600,3301,137,480937,4801,137,480
       Short Long Term Debt 
1,137,480
937,480
1,137,480
1,137,480
0
0
0
0
0
0
0
0
0
0
0
0
24,423,024
27,588,758
29,426,570
28,425,999
34,526,062
36,195,017
37,561,383
37,704,507
41,498,724
0
041,498,72437,704,50737,561,38336,195,01734,526,06228,425,99929,426,57027,588,75824,423,0240000000000001,137,4801,137,480937,4801,137,480
       Accounts payable 
7,273,087
6,597,003
7,348,188
6,583,787
6,070,756
4,648,332
5,077,883
5,881,706
6,910,998
5,820,530
0
0
0
0
7,839,312
6,269,115
6,814,567
6,735,258
8,411,101
7,820,274
7,060,460
7,755,207
6,591,436
7,472,687
7,256,176
0
07,256,1767,472,6876,591,4367,755,2077,060,4607,820,2748,411,1016,735,2586,814,5676,269,1157,839,31200005,820,5306,910,9985,881,7065,077,8834,648,3326,070,7566,583,7877,348,1886,597,0037,273,087
       Other Current Liabilities 
11,635,623
7,974,295
10,108,679
7,109,847
7,751,705
9,683,283
9,943,029
9,706,198
8,631,391
7,933,302
0
0
0
0
8,720,759
9,872,656
10,093,265
40,000
0
0
3,852,614
0
0
4,178,156
4,135,463
0
04,135,4634,178,156003,852,6140040,00010,093,2659,872,6568,720,75900007,933,3028,631,3919,706,1989,943,0299,683,2837,751,7057,109,84710,108,6797,974,29511,635,623
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,354,438
15,912,931
14,410,841
14,256,672
10,598,918
9,169,530
7,765,585
6,189,129
4,814,820
3,305,337
3,305,3374,814,8206,189,1297,765,5859,169,53010,598,91814,256,67214,410,84115,912,93119,354,4380000000000000000
       Long term Debt Total 
0
0
0
37,117,194
33,527,972
33,337,299
37,270,122
31,308,726
26,984,825
25,760,601
24,437,425
23,132,342
24,809,501
23,502,034
21,970,807
20,438,853
18,925,960
15,458,011
13,938,684
13,716,723
0
0
0
0
0
0
00000013,716,72313,938,68415,458,01118,925,96020,438,85321,970,80723,502,03424,809,50123,132,34224,437,42525,760,60126,984,82531,308,72637,270,12233,337,29933,527,97237,117,194000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
193,650
257,516
218,145
179,504
135,801
219,407
335,942
312,107
285,828
0
0285,828312,107335,942219,407135,801179,504218,145257,516193,6500000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
1
0
0
00100010000000000000000000
> Total Stockholder Equity
54,539,286
54,895,622
55,636,127
56,357,105
56,363,062
56,736,224
55,659,716
57,805,455
56,195,147
55,384,129
55,057,295
54,837,979
54,926,651
55,391,300
57,813,065
59,328,829
59,697,998
59,676,877
62,671,208
63,815,558
62,295,048
61,745,692
64,403,335
65,503,137
65,873,603
66,596,005
66,596,00565,873,60365,503,13764,403,33561,745,69262,295,04863,815,55862,671,20859,676,87759,697,99859,328,82957,813,06555,391,30054,926,65154,837,97955,057,29555,384,12956,195,14757,805,45555,659,71656,736,22456,363,06256,357,10555,636,12754,895,62254,539,286
   Common Stock
7,585,250
7,585,250
7,585,250
7,585,250
7,585,250
7,585,250
7,585,250
7,585,250
7,585,250
7,585,250
7,585,250
7,585,250
7,585,250
7,585,250
7,585,250
7,585,250
7,585,250
7,585,250
7,585,250
7,585,250
0
0
0
0
0
0
0000007,585,2507,585,2507,585,2507,585,2507,585,2507,585,2507,585,2507,585,2507,585,2507,585,2507,585,2507,585,2507,585,2507,585,2507,585,2507,585,2507,585,2507,585,2507,585,2507,585,250
   Retained Earnings 
32,522,126
32,874,767
33,611,402
34,326,660
34,336,443
34,706,105
33,629,818
35,779,895
34,149,897
33,342,340
33,021,724
32,807,064
32,895,409
33,362,269
35,785,827
37,283,991
37,478,184
37,455,027
40,449,828
41,598,895
41,024,294
40,483,739
43,149,052
44,233,464
44,880,682
0
044,880,68244,233,46443,149,05240,483,73941,024,29441,598,89540,449,82837,455,02737,478,18437,283,99135,785,82733,362,26932,895,40932,807,06433,021,72433,342,34034,149,89735,779,89533,629,81834,706,10534,336,44334,326,66033,611,40232,874,76732,522,126
   Accumulated Other Comprehensive Income 00000000000000000000000000
   Capital Surplus 
0
0
0
14,450,420
14,450,420
14,450,420
14,450,420
14,450,420
14,450,420
14,450,420
14,450,420
14,450,420
14,450,420
14,450,420
14,450,420
14,450,420
14,450,420
14,450,420
14,450,420
14,450,420
0
0
0
0
0
0
00000014,450,42014,450,42014,450,42014,450,42014,450,42014,450,42014,450,42014,450,42014,450,42014,450,42014,450,42014,450,42014,450,42014,450,42014,450,42014,450,42014,450,420000
   Treasury Stock00000000000000000000000000



6.4. Balance Sheets

Currency in KRW. All numbers in thousands.




6.5. Cash Flows

Currency in KRW. All numbers in thousands.




6.6. Income Statements

Currency in KRW. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue106,387,869
Cost of Revenue-70,169,780
Gross Profit36,218,08936,218,089
 
Operating Income (+$)
Gross Profit36,218,089
Operating Expense-99,497,750
Operating Income6,890,119-63,279,661
 
Operating Expense (+$)
Research Development474,499
Selling General Administrative10,922,837
Selling And Marketing Expenses0
Operating Expense99,497,75011,397,336
 
Net Interest Income (+$)
Interest Income37,830
Interest Expense-1,959,843
Other Finance Cost-0
Net Interest Income-1,922,013
 
Pretax Income (+$)
Operating Income6,890,119
Net Interest Income-1,922,013
Other Non-Operating Income Expenses0
Income Before Tax (EBT)5,140,5886,890,119
EBIT - interestExpense = -1,959,843
4,888,498
6,848,341
Interest Expense1,959,843
Earnings Before Interest and Taxes (EBIT)07,100,431
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax5,140,588
Tax Provision-329,145
Net Income From Continuing Ops4,811,4434,811,443
Net Income4,888,498
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net01,922,013
 

Technical Analysis of Sinsin
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sinsin. The general trend of Sinsin is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sinsin's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Sinsin Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sinsin Pharmaceutical Co. Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 6,150 < 6,240 < 6,320.

The bearish price targets are: 5,670 > 5,580 > 5,500.

Know someone who trades $002800? Share this with them.πŸ‘‡

Sinsin Pharmaceutical Co. Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sinsin Pharmaceutical Co. Ltd. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sinsin Pharmaceutical Co. Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sinsin Pharmaceutical Co. Ltd. The current macd is -59.25169225.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sinsin price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Sinsin. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Sinsin price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Sinsin Pharmaceutical Co. Ltd Daily Moving Average Convergence/Divergence (MACD) ChartSinsin Pharmaceutical Co. Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sinsin Pharmaceutical Co. Ltd. The current adx is 22.99.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Sinsin shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Sinsin Pharmaceutical Co. Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sinsin Pharmaceutical Co. Ltd. The current sar is 5,635.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Sinsin Pharmaceutical Co. Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sinsin Pharmaceutical Co. Ltd. The current rsi is 49.48. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
Sinsin Pharmaceutical Co. Ltd Daily Relative Strength Index (RSI) ChartSinsin Pharmaceutical Co. Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sinsin Pharmaceutical Co. Ltd. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sinsin price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Sinsin Pharmaceutical Co. Ltd Daily Stochastic Oscillator ChartSinsin Pharmaceutical Co. Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sinsin Pharmaceutical Co. Ltd. The current cci is 6.69205031.

Sinsin Pharmaceutical Co. Ltd Daily Commodity Channel Index (CCI) ChartSinsin Pharmaceutical Co. Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sinsin Pharmaceutical Co. Ltd. The current cmo is 6.06250061.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Sinsin Pharmaceutical Co. Ltd Daily Chande Momentum Oscillator (CMO) ChartSinsin Pharmaceutical Co. Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sinsin Pharmaceutical Co. Ltd. The current willr is -54.92957746.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Sinsin is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Sinsin Pharmaceutical Co. Ltd Daily Williams %R ChartSinsin Pharmaceutical Co. Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Sinsin Pharmaceutical Co. Ltd.

Sinsin Pharmaceutical Co. Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sinsin Pharmaceutical Co. Ltd. The current atr is 190.99.

Sinsin Pharmaceutical Co. Ltd Daily Average True Range (ATR) ChartSinsin Pharmaceutical Co. Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sinsin Pharmaceutical Co. Ltd. The current obv is 195,939,027.

Sinsin Pharmaceutical Co. Ltd Daily On-Balance Volume (OBV) ChartSinsin Pharmaceutical Co. Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sinsin Pharmaceutical Co. Ltd. The current mfi is 71.69.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Sinsin Pharmaceutical Co. Ltd Daily Money Flow Index (MFI) ChartSinsin Pharmaceutical Co. Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sinsin Pharmaceutical Co. Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-02-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-02-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-08BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-23MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-07-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Sinsin Pharmaceutical Co. Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sinsin Pharmaceutical Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.481
Ma 20Greater thanMa 505,874.000
Ma 50Greater thanMa 1006,051.600
Ma 100Greater thanMa 2005,785.900
OpenGreater thanClose5,840.000
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Sinsin with someone you think should read this too:
  • Are you bullish or bearish on Sinsin? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sinsin? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sinsin Pharmaceutical Co. Ltd

I send you an email if I find something interesting about Sinsin Pharmaceutical Co. Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Sinsin Pharmaceutical Co. Ltd.

Receive notifications about Sinsin Pharmaceutical Co. Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.